Tag: Antibodies

Therapeutic efficacy and significance of intravitreal injection of ranibizumab for age-related macular degeneration with subfoveal scarring and active lesion

2017, No. 01, Clinical Science

Authors: Li Juanjuan,  Li Hua DOI: 10.3760/cma.j.issn.2095-0160.2017.01.009 Published 2017-01-10 Cite as Chin J Exp Ophthalmol, 2017,35(1): 42-46. Abstract                              [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab is a primary approach to the treatment of wet age-related macular degeneration (wAMD), but whether it is necessary for […]

Influence of repetitive intravitreal ranibizumab for neovascular age-related macular degeneration on retinal pigment epithelium and choroidal thickness

2017, No. 10, Clinical Science

Authors: Qi Hang,  Chen Changzheng,  Su Yu,  Yi Zuohuizi DOI: 10.3760/cma.j.issn.2095-0160.2017.10.012 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 909-913. Abstract                               [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab (IVR) is one of the most effective therapies for neovascular age-related macular degeneration (nAMD). Understanding the influence […]